Clinical Trial Update: Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides [Phase 3]

View source ↗

Summary

Phase 3 trial of Diazoxide Choline Controlled-Release Tablet (DCCR) for hypertriglyceridemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Diazoxide Choline Controlled-Release Tablet (DCCR) (diazoxide choline controlled-release tablet)

Snippet

Sponsor: Essentialis, Inc. | Conditions: Hypertriglyceridemia | Phase 3 | Status: WITHDRAWN